NAPPSA Knowledge Network
NAPPSA Knowledge Library
A draft framework for evergreen, searchable professional collections supporting pharmacists, pharmaceutical scientists, researchers, educators, students, industry professionals, and global health leaders.
Purpose
The Knowledge Library organizes professional knowledge by topic rather than by date. It complements the Intelligence Center, which focuses on current updates. Each collection will eventually connect AJPPS research, FDA and regulatory updates, clinical trials, scientific literature, global health updates, and educational resources.
Core Knowledge Collections
Diabetes & Cardiometabolic
GLP-1s, SGLT2s, diabetes, obesity, and cardiometabolic risk.Oncology
Cancer therapeutics, immunotherapy, biomarkers, and trials.Infectious Disease
Antimicrobial stewardship, HIV, TB, malaria, vaccines.Drug Delivery & Pharmaceutics
Formulation, drug delivery systems, nanomedicine, quality.FDA Approvals & Safety
Approvals, recalls, drug shortages, labeling, safety alerts.African Pharmaceutical Innovation
Africa, Nigeria, manufacturing, regulation, innovation, diaspora collaboration.
GLP-1s, SGLT2s, diabetes, obesity, and cardiometabolic risk.Oncology
Cancer therapeutics, immunotherapy, biomarkers, and trials.Infectious Disease
Antimicrobial stewardship, HIV, TB, malaria, vaccines.Drug Delivery & Pharmaceutics
Formulation, drug delivery systems, nanomedicine, quality.FDA Approvals & Safety
Approvals, recalls, drug shortages, labeling, safety alerts.African Pharmaceutical Innovation
Africa, Nigeria, manufacturing, regulation, innovation, diaspora collaboration.
Specialty Collections
Standard Collection Template
- Executive Overview
- Latest Intelligence
- Featured AJPPS Research
- FDA and Regulatory Updates
- Clinical Trials Watch
- Clinical or Scientific Context
- Educational Resources
- Related Collections
- Source Attribution
Draft Review Notice
This Knowledge Library is currently an internal draft. It has not been added to the public homepage or navigation. Collection pages are being prepared for review before public launch.